Results 21 to 30 of about 14,154 (120)

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Antiretroviral pre‐exposure prophylaxis (PrEP) is less effective in women than expected, partly because drug exposure within the female genital tract is variable and may be influenced by the vaginal microbiome. We developed an integrated pharmacometrics and machine learning framework to evaluate associations between vaginal microbiome composition and ...
Diqin Yan   +6 more
wiley   +1 more source

Antiretoviral therapy and the lipodystrophy syndrome, part 2: Concepts in aetiopathogenesis [PDF]

open access: yes, 2001
Clinical research has indicated that the use of nucleoside reverse transcriptase inhibitor (NRTI) and HIV protease inhibitor (PI) therapy is associated with a risk of long-term toxicity syndromes, and that the aetiopathogenesis of these adverse effects ...
Nolan, D., John, M., Mallal, S.
core  

The Impact of Common Medications on Male Fertility: An Updated Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Compared with those of cytotoxic treatments, the potential effects of common medications on the fertility of men trying to conceive currently or planning to conceive in the future are less well described. The use of common medications may modify the gonadotropic axis, spermatogenesis, and epididymal maturation or alter male ...
Lina Jebli   +7 more
wiley   +1 more source

Hypogonadism in Cisgender Men Living With HIV: Prevalence, Clinical and Metabolic Features

open access: yesAndrology, EarlyView.
ABSTRACT Background Hypogonadism is frequently observed in men living with human immunodeficiency virus (HIV), although its prevalence, etiology, and predictors remain incompletely understood. Objective To evaluate the prevalence of hypogonadism and its association with metabolic factors in men living with HIV (MLWH), on stable antiretroviral therapy ...
Felipe Augusto Azevedo Leao   +8 more
wiley   +1 more source

HIV viral suppression in children and adolescents who transitioned from ritonavir‐boosted lopinavir‐ to dolutegravir‐based antiretroviral therapy in Lesotho

open access: yesHIV Medicine, EarlyView.
Abstract Objectives Children and adolescents living with HIV previously taking ritonavir‐boosted lopinavir (LPV/r)‐based antiretroviral therapy (ART) have been programmatically transitioned to dolutegravir (DTG)‐based regimens in many country programs.
Jacob Blankenberger   +14 more
wiley   +1 more source

Chronic alanine aminotransferase elevation in people with HIV: Time trends over 22 years and genetic predisposition

open access: yesHIV Medicine, EarlyView.
Abstract Introduction Chronic elevation of alanine aminotransferase (cALT) is common in people with HIV. Published reports on cALT prevalence time trends have not been uniform. It is unknown whether genetic background is associated with cALT in people with HIV. Methods cALT was defined as ALT levels (male, >50 U/L, female, >35 U/L) at ≥2 consecutive, 6‐
Noemi R. Simon   +72 more
wiley   +1 more source

Impact of the coronavirus disease 2019 (COVID‐19) pandemic and stringency index on the dispensation of human immunodeficiency virus post‐exposure prophylaxis in Brazil: A retrospective study

open access: yesHIV Medicine, EarlyView.
Abstract Introduction The coronavirus disease 2019 (COVID‐19) pandemic substantially affected healthcare systems worldwide and may have compromised access to human immunodeficiency virus (HIV) prevention strategies, including post‐exposure prophylaxis (HIV‐PEP).
Matheus Negri Boschiero   +2 more
wiley   +1 more source

Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV. [PDF]

open access: yes, 2020
: Associations between markers of liver and renal dysfunction and NRTI plasma exposure are ill-defined. As part of a large cohort study (POPPY), we analysed associations between ALT and eGFR results in people living with HIV on tenofovir (TFV) disoproxil
Boffito, Marta   +43 more
core   +2 more sources

The Safety, Pharmacokinetics, and Antiviral Activity of ABI‐4334, A Novel Next‐Generation Hepatitis B Capsid Assembly Modulator

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Novel, well‐tolerated, short‐term therapeutics for chronic hepatitis B virus infection (cHBV) are needed. ABI‐4334 is a next‐generation capsid assembly modulator that targets the HBV core protein. The safety, tolerability, and pharmacokinetics of ABI‐4334 in healthy volunteers and participants with cHBV and antiviral effects in participants ...
Edward J. Gane   +11 more
wiley   +1 more source

sj-pdf-1-avt-10.1177_13596535221077487 – Supplemental Material for Efficacy of Second-line Dolutegravir Plus 2 NRTIs by Baseline NRTI Resistance and NRTI Use in the DAWNING Study

open access: yes, 2022
Supplemental Material, sj-pdf-1-avt-10.1177_13596535221077487 for Efficacy of Second-line Dolutegravir Plus 2 NRTIs by Baseline NRTI Resistance and NRTI Use in the DAWNING Study by Dannae Brown, Richard Kaplan, Marcelo Losso, Carlos Brites, Ruolan Wang ...
Jörg Sievers (12175849)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy